drugset / Trial / NCT05786807

Effect of H. Pylori Eradication on Alleviating Symptoms in Functional Dyspepsia Patients

NCT05786807

Phase 4 Unknown 315 enrolled Wonkwang University Hospital
NaSingle-groupOpen-labelTreatment

Summary

In patients with Helicobacter pylori-positive functional dyspepsia, long-term follow-up for 6 months after standard triple therapy first-line eradication treatment, the rate of symptom disappearance and degree of improvement of functional dyspepsia were confirmed through changes in symptom scores and changes in drug usage, and eradication treatment The purpose of this study is to confirm the rate of symptom disappearance according to the results.

Timeline

Start
2022-03-07
Primary completion
2023-11-30
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Background Amoxicillin Other / unclassified 500 mg
Background Clarithromycin Small molecule 500 mg
Background Tegoprazan Other / unclassified 50 mg